Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Current Leases (2019 - 2025)

Historic Current Leases for Cue Biopharma (CUE) over the last 7 years, with Q3 2025 value amounting to $2.0 million.

  • Cue Biopharma's Current Leases fell 2984.46% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 2984.46%. This contributed to the annual value of $3.5 million for FY2024, which is 510.69% up from last year.
  • Cue Biopharma's Current Leases amounted to $2.0 million in Q3 2025, which was down 2984.46% from $2.1 million recorded in Q2 2025.
  • Cue Biopharma's Current Leases' 5-year high stood at $5.4 million during Q1 2022, with a 5-year trough of $2.0 million in Q3 2025.
  • Moreover, its 5-year median value for Current Leases was $3.4 million (2023), whereas its average is $3.6 million.
  • As far as peak fluctuations go, Cue Biopharma's Current Leases skyrocketed by 1470.93% in 2021, and later crashed by 3815.89% in 2023.
  • Over the past 5 years, Cue Biopharma's Current Leases (Quarter) stood at $4.9 million in 2021, then tumbled by 33.09% to $3.3 million in 2022, then grew by 2.06% to $3.4 million in 2023, then rose by 5.11% to $3.5 million in 2024, then plummeted by 42.63% to $2.0 million in 2025.
  • Its Current Leases stands at $2.0 million for Q3 2025, versus $2.1 million for Q2 2025 and $3.6 million for Q1 2025.